Login to Your Account



e-Therapeutics Raises $63M to Fund Solid Tumor Drug

By Nuala Moran
Staff Writer

Wednesday, February 13, 2013
e-Therapeutics plc is copper-bottoming its future, raising £40 million (US$62.66) in a share issue which, added to existing resources of £8 million, will fund the network pharmacology specialist until 2017.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription